Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases

Clinical and Experimental Immunology

Volumn 186, Issue 1, 2016, Pages 39-45

  Pica, F ^a   Chimenti, M S ^b   Gaziano, R ^a   Bue C ^a   Casalinuovo, I A ^a   Triggianese, P ^b   Conigliaro, P ^b   Di Carlo, D ^a   Cordero, V ^c   Adorno, G ^c   Volpi, A ^b   Perricone, R ^b   Garaci, E ^a,d  

^a Departments of Experimental Medicine and Surgery   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

autoimmune diseases; psoriatic arthritis; rheumatoid arthritis; systemic lupus erythematosus; thymosin 1

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; THYMOSIN ALPHA1;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84991254122     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12833     Document Type: Article

References (34)

1. Goldstein AL, Guha A, Zatz MM, Hardy MA, White A. Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci USA 1972; 69:1800–3.
2. Sarandeses CS, Covelo G, Díaz-Jullien C, Freire M. Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 2003; 278:13286–93.
3. Franco FJ, Diaz C, Barcia M, Freire M. Thymosin alpha 1 is a native peptide in several tissues. Biochim Biophys Acta 1992; 1120:43–8.
4. Garaci E, Favalli C, Pica F et al. Thymosin alpha 1: from bench to bedside. Ann NY Acad Sci 2007; 1112:225–34.
5. Romani L, Bistoni F, Montagnoli C et al. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Ann NY Acad Sci 2007; 1112:326–38.
6. Garaci E, Mastino A, Pica F, Favalli C. Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice. Cancer Immunol Immunother 1990; 32:154–60.
7. Goldstein AL, Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009; 9:593–608.
8. Nepravishta R, Mandaliti W, Eliseo T et al. Thymosin α1 inserts N terminus into model membranes assuming a helical conformation. Expert Opin Biol Ther 2015; 15:S71–81.
9. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358:903–11.
10. Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R. Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. Autoimmun Rev 2013; 12:599–606.
11. Rother N, van der Vlag J. Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus. Front Immunol 2015; 6:610.
12. Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P. Epigenetic alterations and autoimmune disease. J Dev Orig Health Dis 2011; 2:258–64.
13. Bowes J, Budu-Aggrey A, Huffmeier U et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun 2015; 6:6046.
14. Conigliaro P, Triggianese P, Perricone C et al. Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during Etanercept treatment. Clin Exp Immunol 2014; 177:234–43.
15. Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015; 6:e1887.
16. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665–73.
17. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315–24.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
19. Van der Heijde DM, van't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20:579–81.
20. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29:288–91.
21. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2016. ISBN 3-900051-07-0, Available at: https://www.R-project.org/
22. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9:811–8.
23. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012; 38:J109–19.
24. Romani L, Bistoni F, Perruccio K et al. Thymosin a1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006; 108:2265–74.
25. Lavastida MT, Goldstein AL, Daniels JC. Thymosin administration in autoimmune disorders. Thymus 1981; 2:287–95.
26. Torcia MG, Nencioni L, Clemente AM et al. Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL 10 production in males. PLOS ONE 2012; 7:e39853.
27. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010; 10:594–604.
28. Veale DJ, Fearon U. What makes psoriatic and rheumatoid arthritis so different? RMD Open 2015; 1:e000025.
29. McClure JE, Lameris N, Wara DW, Goldstein AL. Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1. J Immunol 1982; 128:368–75.
30. Mandaliti W, Nepravishta R, Sinibaldi Vallebona P, Pica F, Garaci E, Paci M. Thymosin α1 interacts with exposed phosphatidylserine in membrane models and in cells and uses serum albumin as carrier. Biochemistry 2016; 55:1462–72.
31. Sherman KE, Jones CC, Goldstein AL, Naylor PH. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus. Viral Immunol 1991; 4:195–9.
32. Molinero P, Soutto M, Benot S, Hmadcha A, Guerrero JM. Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans. J Neuroimmunol 2000; 103:180–8.
33. Jou YC, Tsai YS, Hsieh HY et al. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma. Urol Oncol 2013; 31:1806–11.
34. Serafino A, Pierimarchi P, Pica F et al. Thymosin α1 as a stimulatory agent of innate cell-mediated immune response. Ann NY Acad Sci 2012; 1270:13–20.